CLINICAL_TRIALS
trial_result
· 2020-09-01
Clinical Trial Update: Carboplatin Plus Docetaxel (Taxotere) in Anaplastic Prostate Cancer [Phase 2]
Summary
Phase 2 clinical trial update evaluating carboplatin plus docetaxel in anaplastic prostate cancer.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: M.D. Anderson Cancer Center | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2020-09-01